(3-Fluoro-6-methoxyphenyl)acetaldehyde, 97.0%, 1g

(1-tosyl-1H-Indol-3-yl)boronic acid, 95.0%, 100mg

(5-Bromopyridin-2-yl)methanamine dihydrochloride, 95.0%, 25g

2-Bromo-5-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 5g

4-Methoxy-[1,1'-biphenyl]-3-carboxylic acid, 97%, 250mg

4,5-Bis(dicyclohexylphosphino)-9,9-dimethylxanthene>97.0%(GC)1g

GC capillary column ROTI®Cap-5, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-Chloro-3-(chlorosulfonyl)benzoic acid, 95.0%, 1g

TERT-BUTYL (4-N-BOC-AMINOBENZYL)CARBAMATE, 95.0%, 250mg

D-(-)-Lyxose>98.0%(HPLC)5g

2,4-Dichloro-3-fluorobenzonitrile, 95.0%, 5g

Acetylenedicarboxylic Acid>90.0%(HPLC)5g

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)azetidine-1-carboxylate, 97%, 500mg